MARKET

HSDT

HSDT

HELIUS MEDICAL
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.920
+0.040
+2.13%
After Hours: 1.930 +0.01 +0.52% 17:21 09/13 EDT
OPEN
1.880
PREV CLOSE
1.880
HIGH
1.950
LOW
1.880
VOLUME
23.83K
TURNOVER
--
52 WEEK HIGH
10.76
52 WEEK LOW
1.750
MARKET CAP
49.73M
P/E (TTM)
-4.1308
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HSDT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HSDT News

  • Helius Medical Technologies, Inc. Announces Addition of a New PoNS™ Clinic in Quebec City, Canada
  • GlobeNewswire.2d ago
  • FINAL DEADLINE - Helius Medical Technologies, Inc. (HSDT) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Deadline: September 9, 2019
  • ACCESSWIRE.6d ago
  • MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  • GlobeNewswire.6d ago
  • HSDT FINAL SEPT. 9 DEADLINE, ROSEN, A TOP RANKED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important Monday Deadline in Securities Class Action - HSDT
  • ACCESSWIRE.09/08 20:02

More

Industry

Advanced Medical Equipment & Technology
-0.04%
Healthcare Equipment & Supplies
-0.35%

Hot Stocks

Name
Price
%Change

About HSDT

Helius Medical Technologies, Inc. is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain's ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device. The device, when used in combination with physiotherapy, is designed to enhance the brain's ability to compensate for damage due to trauma or disease. The Company's PoNS device is designed to induce cranial nerve non-invasive neuromodulation through an increase in stimulation of the facial and trigeminal nerves, which innervate the tongue. The PoNS device is developed to deliver to the tongue a non-invasive neurostimulation, in a form that induces neuromodulation. The PoNS device is an electrical pulse generator that delivers controlled electrical stimulation to the tongue.
More

Webull offers Helius Medical Technologies Inc (HSDT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.